Edwards Lifesciences (EW) Price to Sales (2009 - 2026)

Edwards Lifesciences has reported Price to Sales for 18 years, with the latest figure at 29.96 in Q2 2026.

• On a quarterly basis, Price to Sales changed 0.17% year-over-year to 29.96 in Q2 2026; TTM through Jun 2026 was 8.01, a 0.97% decrease from a year earlier, with the FY2025 full-year figure at 8.16, up 1.85% from the prior year.
• Price to Sales was 29.96 for Q2 2026 at Edwards Lifesciences, up from 28.03 in the prior quarter.
• The five-year high for Price to Sales was 105.57 in Q4 2022, with the low at 28.03 in Q1 2026.
• Average Price to Sales over 5 years is 40.03, with a median of 34.99 recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Price to Sales surged 73.62% in 2022, then sank 65.72% in 2023.
• Over 5 years, Price to Sales stood at 105.57 in 2022, then tumbled by 65.72% to 36.19 in 2023, then declined by 13.12% to 31.44 in 2024, then grew by 0.31% to 31.54 in 2025, then fell by 5.01% to 29.96 in 2026.
• The last three Price to Sales figures came in at 29.96 (Q2 2026), 28.03 (Q1 2026), and 31.54 (Q4 2025), per Business Quant data.